When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RDY - Dr. Reddy's launches generic version of Bayer's kidney/liver cancer drug Nexavar in US
Dr. Reddy's Laboratories Ltd
Dr. Reddy's Laboratories (NYSE:RDY) launched its sorafenib tablets, a generic of Bayer's (OTCPK:BAYRY) (OTCPK:BAYZF) kidney/liver/thyroid cancer drug Nexavar (sorafenib), in the U.S. following the approval by the U.S. Food and Drug Administration (FDA). Dr. Reddy's sorafenib tablets, USP, 200 mg tablets are available in bottle count sizes of 120, according to the company's June 14 press release.